Royal Bank Of Canada Immuneering Corp Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Immuneering Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 11,294 shares of IMRX stock, worth $24,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,294

Holding current value

$24,733

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.03 - $3.21 $11,632 - $36,253	11,294 New	11,294 $28,000
Q1 2024 Nov 05, 2024	BUY	$1.91 - $7.32 $1,497 - $5,738	784 New	784 $2,000
Q1 2024 May 15, 2024	SELL	$1.91 - $7.32 $11,994 - $45,969	-6,280 Reduced 88.9%	784 $2,000
Q4 2023 Feb 14, 2024	BUY	$4.84 - $8.44 $12,133 - $21,159	2,507 Added 55.01%	7,064 $51,000
Q3 2023 Nov 14, 2023	BUY	$7.21 - $10.68 $22,278 - $33,001	3,090 Added 210.63%	4,557 $34,000
Q2 2023 Aug 14, 2023	BUY	$6.49 - $13.36 $9,488 - $19,532	1,462 Added 29240.0%	1,467 $14,000
Q1 2023 May 15, 2023	SELL	$3.78 - $10.38 $287 - $788	-76 Reduced 93.83%	5 $0
Q4 2022 Feb 14, 2023	BUY	$4.09 - $15.0 $331 - $1,215	81 New	81 $0
Q2 2022 Aug 15, 2022	SELL	$3.89 - $7.81 $4,539 - $9,114	-1,167 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.47 - $16.99 $5,143 - $13,507	-795 Reduced 40.52%	1,167 $8,000
Q4 2021 Feb 14, 2022	BUY	$16.12 - $31.02 $17,570 - $33,811	1,090 Added 125.0%	1,962 $32,000
Q3 2021 Nov 15, 2021	BUY	$17.0 - $32.84 $14,824 - $28,636	872 New	872 $23,000

Others Institutions Holding IMRX

# of Institutions

Shares Held

4.64M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

1.07M
Shares

$2.34 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

810K
Shares

$1.77 Million
0.0% of portfolio
Black Rock Inc. New York, NY

533K
Shares

$1.17 Million
0.0% of portfolio
Morgan Stanley New York, NY

449K
Shares

$983,991
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

246K
Shares

$539,331
0.0% of portfolio

View Full List

About Immuneering Corp

Ticker IMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,392,300
Market Cap $57.8M
Description
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...

More about IMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account